Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2019-10-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
第三届监事会第三十二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolution passed at the 32nd meeting of the third Supervisory Board of the company. It specifically mentions the review and approval of the company's 2019 third quarter report. However, the document itself does not contain the actual financial data or the full report; it states that the detailed content is available on the official disclosure website. The document length is short (901 characters), and it serves as a notice of the meeting resolution and the approval of the quarterly report rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement related to a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement about the approval of a quarterly report without containing the substantive financial data.
2019-10-29 Chinese
2019年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 Third Quarter Report" of 三诺生物传感股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance and shareholder information. The length is substantial (15,000 characters), and it includes actual financial statements and analysis for the third quarter of 2019. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2019-10-29 Chinese
关于获得政府补助的进展公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the receipt of government subsidy funds by the company. It references a previous announcement and provides details about the subsidy amount and accounting treatment but does not contain any financial statements or detailed financial analysis. The document length is only 706 characters, which is quite short and typical for an announcement rather than a full report. It does not present an annual or interim report, audit report, or earnings release. It is not a regulatory certification or officer attestation. The content fits best as a regulatory announcement about government subsidy progress and receipt, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-10-18 Chinese
关于使用闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from SanNuo Biological Sensor Co., Ltd. regarding the progress of using idle self-owned funds to purchase low-risk financial products. It details the approval process, investment risk analysis, and the impact on the company. The document does not contain financial statements or detailed financial performance data but rather informs shareholders and the public about the company's investment activities and approvals related to fund usage. The length is 2485 characters, which is relatively short and the content is an update on financing activities rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2019-10-16 Chinese
关于取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (791 characters) from a company about obtaining a medical device registration certificate issued by a regulatory authority (Hunan Provincial Drug Administration). It includes details about the product and registration validity but does not contain financial data, management discussion, or detailed report content. It is an official company announcement related to regulatory approval rather than a financial report or management information. The document is not a report itself but an announcement of a regulatory event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-10-15 Chinese
2019年前三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast announcement for the first three quarters of 2019 by 三诺生物传感股份有限公司. It includes estimated net profit figures for the period ending September 30, 2019, and a detailed explanation of the reasons for performance changes. It explicitly states that the financial data is preliminary and unaudited, and that detailed financial data will be disclosed in the company's 2019 third quarter report. The document is short (1395 characters) and serves as a forward-looking earnings preview rather than a full financial report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly/periodical financial results with key highlights only, not a full interim report or audited financial statements.
2019-10-11 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.